The effects of S-adenosylmethionine on clinical pathology and redox potential in the red blood cell, liver, and bile of clinically normal cats

Journal of Veterinary Internal Medicine

Volumn 19, Issue 3, 2005, Pages 303-314

  Center, S A ^a   Randolph, J F ^a   Warner, K L ^a   McCabe McClelland, J ^a   Foureman, P ^a   Hoffmann, W E ^b   Erb, H N ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Bile acids; Erythrocyte osmotic fragility; Glutathione; Glycogen; Thiobarbiturate reacting substances

Indexed keywords

BILE ACID; DNA; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCOGEN; PROTEIN; S ADENOSYLMETHIONINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE; CAT; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE FRAGILITY; FEMALE; HISTOLOGY; LIVER; LIVER FUNCTION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PATHOLOGY; STOMACH;

ANIMALS; BILE; CATS; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTES; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LIVER; LONGITUDINAL STUDIES; OSMOTIC FRAGILITY; OXIDATION-REDUCTION; S-ADENOSYLMETHIONINE; TABLETS, ENTERIC-COATED;

ANIMALIA; FELIS CATUS;

EID: 19744376702     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2005)19[303:TEOSOC]2.0.CO;2     Document Type: Article

References (98)

1. Friedel HA, Goa KL, Benfield P. S-adenosyl-L-methionine: A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 1989;38:389-416.
2. Stramentinoli G. Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics. Am J Med 1987;83:35-42.
3. Mudd SH, Poole JR. Labile methyl group balances for normal humans in various dietary regimens. Metabolism 1975;24:721-735.
4. Almasio P, Bortolini M, Pagliaro L, et al. Role of S-adenosyl-L- methionine in the treatment of intrahepatic cholestasis. Drugs 1990;40:111-123.
5. Center SA. Chronic liver disease: Current concepts of disease mechanisms. J Small Anim Pract 1999;40:106-114.
6. Finkelstein JD, Kyle WE, Martin JJ, Pick AM. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochem Biophys Res Commun 1975;66:81-87.
7. Snow NS. Some observations on the reactive sulfhydryl groups in haemoglobin. Biochem J 1962;84:360-364.
8. Harvey JW, Kaneko JJ. Mammalian erythrocyte metabolism and oxidant drugs. Toxicol Appl Pharmacol 1977;42:253-261.
9. Christopher MM, White JG, Eaton JW. Erythrocyte pathology and mechanisms of Heinz body-mediated hemolysis in cats. Vet Pathol 1990;27:299-310.
10. Jain NC. Studies on the occurrence and persistence of Heinz bodies in erthyrocytes of the cat. Folia Haematol 1973;99:28-38.
11. Blue J, Weiss L. Vascular pathways in nonsinusoidal red pulpan electron microscope study of the cat spleen. Am J Anat 1981;161:135-168.
12. Christopher MM, Perman V, Eaton JW. Contribution of propylene glycol-induced Heinz body formation to anemia in cats. J Am Vet Med Assoc 1989;194;1045-1056.
13. Christopher MM. Relation of endogenous Heinz bodies to disease and anemia in cats. J Am Vet Med Assoc 1989;194:1089-1095.
14. Christopher MM, Broussard JD, Peterson ME. Heinz body formation associated with ketoacidosis in diabetic cats. J Vet Intern Med 1995;9:24-31.
15. Chawla RK, Bonkovsky, Galambo JT. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease. Drugs 1990;40:98-110.
16. Manzillo G, Piccinino F, Surrenti C, et al. Multicentre double-blind placebo-controlled study of intravenous and oral S-adenosyl-L-methionine (SAMe) in cholestasis patients with liver disease. Drug Invest 1992;4(Suppl 4E):90-100.
17. Vendemiale G, Altomare E, Trizio T, et al. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol 1989;24:407-415.
18. Mato JM, Corrales F, Martin-Duce A, et al. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part 1. Drugs 1990;40:58-64.
19. Piccinino F, Sagnelli E, Pasquale G, et al. S-adenosyl-methionine in patients with chronic active hepatitis treated with steroids. Ital J Gastroenterol 1982;14:186-188.
20. Torta R, Zanalda E, Rocca P, et al. Inhibitory activity of S-adenosyl-L-methionine on serum gamma-glutamyl-transpeptidase increase induced by psychodrugs and anticonvulsants. Curr Ther Res 1988;44:144-159.
21. Frezza M, Pozzato G, Chiesa L, et al. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. Gastroenterology 1990;99:211-215.
22. Frezza M, Centini G, Cammareri G, et al. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology 1990:37(Suppl 111): 122-125.
23. Frezza M, Terpin M. The use of S-adenosyl-L-methionine in the treatment of cholestatic disorders. A meta-analysis of clinical trials. Drug Invest 1992;4:101-108.
24. Di Padova C, DiPadova F, Tritapepe R, et al. S-adenosyl-methionine protection against alpha-napththyl-isothiocyanate-induced cholestasis in the rat. Toxicol Lett 1985;29:131-136.
25. Di Padova C, Tritappepe R, Gammareri G, et al. S-adenosyl-L-methionine antagonizes ethynylestradiol-induced bile cholesterol supersaturation in humans without modifying the estrogen plasma kinetics. Gastroenterology 1982;82:223-227.
26. Muriel P, Suarez OR, Gonzalez P, et al. Protective effect of S-adenosyl-1-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol 1994;21:95-102.
27. Placidi GF, Stramentinoli G, Pezzoli C, et al. A study of the distribution of radioactive S-adenosylmethionine in the experimental animal. Monogr Gesamtgeb Psychiatr Psychiatry Ser 1978;18:100-110.
28. Ponsoda X, Jover R, Gomez-Lechon MJ, et al. Intracellular glutathione in human hepatocytes incubated with S-adenosyl-L-methionine and GSH-depleting drugs. Toxicology 1991;70:293-302.
29. Lieber CS, Casini A, DeCarli LM, et al. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 1990;11:165-172.
30. Bonasch H, Cornelius CE. Indocyanine green clearance - A liver function test for the dog. Am J Vet Res 1964;25:254-256.
31. Center SA, Bunch SE, Baldwin BH, et al. Comparison of sulfobromophthalein and indocyanine green clearances in the cat. Am J Vet Res 1983;44:727-733.
32. Prins HK, Loos JA. Gutathione. In: Yunis J, ed. Biochemical Methods in Red Cell Genetics. New York, NY: Academic Press; 1969:115-137.
33. Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-310.
34. Kwon TW, Watts BM. Determination of malonaldehyde by ultraviolet spectrophotometry. J Food Sci 1963:28:627-630.
35. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980;106:207-212.
36. Center SA, Warner KL, Erb HN. Liver glutathione concentrations in dogs and cats with naturally occurring liver disease. Am J Vet Res 2002;63:1187-1197.
37. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-278.
38. Lo S, Russell JC, Taylor AW. Determination of glycogen in small tissue samples. J Appl Physiol 1970;28:234-236.
39. Center SA, Leveille CR, Baldwin BH, et al. Direct spectrometric determination of serum bile acids in the dog and cat. Am J Vet Res 1984;45:2043-2050.
40. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
41. Downs TR, Wilfinger WW. Fluorometric quantification of DNA in cells and tissue. Anal Biochem 1983;131:538-547.
42. Beutler E. Active transport of glutathione disulfide from erythrocytes. In: Larsson A, Orrenius S, Holmgren A, Mannervik B, eds. Functions of Glutathione: Biochemical Physiological, Toxicological, and Clinical Aspects. New York, NY: Raven Press; 1983:65-74.
43. Beutler E. Energy metabolism and maintenance of erythrocytes. In: Williams WJ, Beutler E, Erslev AJ, eds. Hematology, 4th ed. New York, NY: McGraw Hill; 1990:355-368.
44. Dass PD, Bermes EW, Holmes EW. Renal and hepatic output of glutathione in plasma and whole blood. Biochem Biophys Acta 1992;1156:99-102.
45. Galli F, Rovidati S, Benedetti S. Over-expression of erythrocyte glutathione S-transferase in uremia and dialysis. Clin Chem 1999;45:1781-1788.
46. Clemens MR, Waller HD. Lipid peroxidation in erythrocytes. Chem Phys Lipids 1987;45:251-268.
47. Christopher MM, Perman V, White JG, et al. Propylene glycolinduced heinz body formation and d-lactic acidosis in cats. In: Brewer GJ, ed. The Red Cell: Seventh Ann Arbor Conference. New York, NY: Alan R Liss Inc; 1989:69-92.
48. Kaneko JJ. Comparative erythrocyte metabolism. In: Brandly CA, Cornelius CE, eds. Advances in Veterinary Science and Comparative Medicine. New York, NY: Academic Press; 1974:117-153.
49. Harvey JW, Kaneko JJ. Erythrocyte enzyme activities and glutathione levels of the horse, cat, dog and man. Comp Biochem Physiol B 1975;52:507-510.
50. Kurata M, Suzuki M, Agar NS. Antioxidant systems and erythrocyte life-span in mammals. Comp Biochem Physiol B 1993;106:477-487.
51. Dumaswala UJ, Zhuo L, Jacobsen DW, et al. Protein and lipid oxidation of banked human erythrocytes: Role of glutathione. Free Radic Biol Med 1999;27:1041-1049.
52. Webb CV, Twedt DC, Fettman MJ, et al. S-adenosylmethionine (SAMe) in a feline acetaminophen model of oxidative injury. J Feline Med Surg 2003;5:69-75.
53. Smith JE, Agar NS. The effect of phlebotomy on canine erythrocyte metabolism. Res Vet Sci 1975;18:231-236.
54. Roth EF Jr, Grossman HA, Tanowitz H, et al. Reticulocytes contain increased amounts of reduced glutathione except when produced by acetylphenylhydrazine. Biochem Med 1979;21:333-341.
55. Rettig MP, Low PS, Gimm A, et al. Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood 1999;93:376-384.
56. 14. Proc Soc Exp Biol Med 1966;123:783-784.
57. Kakimoto H, Kawata S, Imai Y. Changes in lipid composition of erythrocyte membranes with administration of S-adenosyl-L-methionine in chronic liver disease. Gastroenterol Jpn 1992;27:508-513.
58. Muriel P. S-adenosyl-L-methionine prevents and reverses erythrocyte membrane alterations in cirrhosis. J Appl Toxicol 1993;13:179-182.
59. Sato Y, Miura T, Suzuki Y. Interaction of pentoxifylline with human erythrocytes. III. Comparison of fluidity change of erythrocyte membrane caused by S-adenosyl-L-methionine with that by pentoxifylline. Chem Pharm Bull (Tokyo) 1991;39:468-473.
60. Pezzoli C, Fiorini RM, Curatola G, et al. S-adenosylmethionine protects against erythrocyte membrane alterations induced in rabbits by cholesterol-rich diet. Pharmacol Res Commun 1983;15:785-795.
61. Bontemps F, Van Den Berghe G. Metabolism of exogenous S-adenosylmethionine in isolated rat hepatocyte suspensions: Methylation of plasma-membrane phospholipids without intracellular uptake. Biochem J. 1997;327:383-389.
62. Pascale R, Daino L, Garcea R, et al. Inhibition by ethanol of rat liver plasma membrane (Na+,K+)ATPase: Protective effect of S-adenosyl-L-methionine, L-methionine, and N-acetylcysteine. Toxicol Appl Pharmacol 1989;97:216-229.
63. Muriel P, Mourelle M. Characterization of membrane fraction lipid composition and function of cirrhotic rat liver. Role of S-adenosyl-L- methionine. J Hepatol 1992;14:16-21.
64. Kolanjiappan K, Manoharan S, Kayalvizhi M. Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta 2002;326:143-149.
65. Martos MR, Hendry BM, Rodriguez-Puyol M, et al. Haemodialyser biocompatibility and erythrocyte structure and function. Clin Chim Acta 1997;265:235-246.
66. Matteucci E, Giampietro O. Oxidative stress in families of type 1 diabetic patients. Diabetes Care 2000;23:1182-1186.
67. Taniguchi M, Hirayama K, Yamaguchi K, et al. Nutritional aspects of glutathione metabolism and function. In: Dolphin D, Avramovic O, Poulson R, eds. Glutathione: Chemical, Biochemical, and Medical Aspects. New York, NY: John Wiley & Sons; 1989:645-727.
68. National Research Council. Nutrient Requirements for Cats. Washington, DC: National Academy Press; 1986.
69. Stipanuk MH, Bagley PJ, Hou YC, et al. Hepatic regulation of cysteine utilization for taurine synthesis. Adv Exp Med Biol 1994;359:79-89.
70. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol 2000;32:39-47.
71. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis 1996IV;131-159.
72. Poli G. Pathogenesis of liver fibrosis: Role of oxidative stress. Mol Aspects Med 2000;21:49-98.
73. Losser M-R, Payen D. Mechanisms of liver damage. Semin Liver Dis 1996;16:356-367.
74. Deleve LD, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 1991;52;287-305.
75. Mato JM, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: Molecular mechanisms and clinical implications. Pharmacol Ther 1997;73:265-280.
76. Bottiglieri T. S-adenosyl-L-methionine (SAME): From the bench to the bedside-molecular basis of a pleiotrophic molecule. Am J Clin Nutr 2002;76:1151S-1157S.
77. Martinez-Chantar ML, Garcia-Trevijano ER, Latasa MU, et al. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury. Am J Clin Nutr 2002;76:1177S-1182S.
78. Heuman DM, Moore EW, Vlahcevic ZR. Pathogenesis and dissolution of gallstones. Physiology and pathophysiology of enterohepatic circulation of bile acids. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease, 3rd ed. Philadelphia, PA: WB Saunders; 1996:1833-1876.
79. Dawes LG, Moore EW, Rege RV, et al. Canine bile contains anticrystallization factors that inhibit precipitation of calcium carbonate. Hepatology 1991;14:701-706.
80. Washizu T, Ikenaga H, Washizu M, et al. Bile acid composition of dog and cat gall-bladder bile. Jpn J Vet Sci 1990;52:423-425.
81. Radberg G, Friman S, Samsioe G, et al. Direct measurement of enterohepatic circulation of bile acids in the cat: Influence of contraceptive steroids and oophorectomy. Scand J Gastroenterol 1987;22:827-832.
82. Ballatori N, Rebbeor JF. Roles of MRP2 and oatpl in hepatocellular export of reduced glutathione. Semin Liver Dis 1998;18:377-387.
83. Paulusma CC, van Geer MA, Evers R, et al. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 1999;228:393-401.
84. Bouchard G, Tuchweber B, Youseff IM. Bile salt independent flow during bile salt-induced choleresis and cholestasis in the rat: Role of biliary thiol secretion. Liver 2000;20:27-37.
85. Suzuki H, Sugiyama Y. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2. Semin Liver Dis 1998;18:359-376.
86. Akerboom TP, Bilzer M, Sies H. The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused liver. J Biol Chem 1982;257:4248-4252.
87. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 1999;27:922-935.
88. Fittschen C, Bellamy JEC. Prednisone-induced morphologic and chemical changes in the liver of dogs. Vet Pathol 1984;21:399-401.
89. Ballard FJ. Glucose utilization in the mammalian liver. Comp Biochem Physiol 1965;14:437-443.
90. Kettelhut IC, Foss MC, Migliorini RH. Glucose homeostasis in a carnivorous animal (cat) and in rats fed a high-protein diet. Am J Physiol 1980;239:R437-R444.
91. Ziesel SM, Poole JR. Dietary intake of methionine: Influence on brain S-adenosylmethionine. In: Usdin E, Borchardt RT, Creveling CR, eds. Transmethylations. Amsterdam, The Netherlands: Elsevier/North-Holland; 1979:59-68.
92. Cabrero C, Martin Duce A, Ortiz P, et al. Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis. Hepatology 1988;88:1530-1534.
93. Duce AM, Ortiz P, Cabrero C, et al. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988;88:65-68.
94. Pisi E, Marchesini G. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis. Drugs 1990;40:65-72.
95. Lu SC, Huang ZZ, Yang HP, et al. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol 2000;379:G178-G185.
96. Mato JM, Corrales FJ, Lu SC, et al. S-adenosylmethionine: A control switch that regulates liver function. FASEB J 2002; 16:15-26.
97. Trainor D, Center SA, Randolph JF, et al. Urine sulfated and nonsulfated bile acids as a diagnostic test for liver disease in cats. J Vet Intern Med 2003;17:145-153.
98. Smith CV, Mitchell JR. Pharmacological aspects of glutathione in drug metabolism. In: Dolphin D, Avramovic O, Poulson R, eds. Glutathione: Chemical, Biochemical, and Medical Aspects. New York, NY: John Wiley & Sons; 1989:1-43.